InvestorsHub Logo
Followers 20
Posts 5530
Boards Moderated 0
Alias Born 01/04/2012

Re: silvr_surfr post# 8068

Sunday, 04/22/2018 4:12:52 PM

Sunday, April 22, 2018 4:12:52 PM

Post# of 15238
Silvr, the location date is interesting (good observation), however it could also be related to the many Androgel lawsuits. That being said there is no denying that in 2011 Abbott/AbbVie was interested in female testosterone replacement. In light of the fact ATRS secured the patent to treat HSDD and was working a broader TRT patent, in addition to BPAX working on the CV reduction patents, it appears AbbVie is the most likely partner in an NDA.

I have yet to see another plausible explanation for the lack of information on an arguably price moving asset.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News